Harvard T.H. Chan School of Public Health’s Barry Bloom, Joan L. and Julius H. Jacobson Research Professor of Public Health, offers context about the news that two experimental vaccines appear…

Mortality rates after cancer surgery declined for Black as well as white patients during a recent 10-year period, although the mortality gap between the two groups did not narrow, according…

When Vertex Pharmaceuticals announced last month that its investigational stem-cell-derived replacement therapy was, in conjunction with immunosuppressive therapy, helping the first patient in a Phase 1/2 clinical trial robustly reproduce…

An artificial intelligence-based method for identifying patients who are at risk for atrial fibrillation has been developed by a team led by researchers at Harvard-affiliated Massachusetts General Hospital and the…

Every day, hundreds of thousands of new COVID-19 cases and thousands of new deaths are still being reported worldwide, creating a need for drugs that can combat the disease caused…

Just about everyone knows that exercise is good for you. Some people can even rattle off reasons it keeps your muscles and joints strong, and how it fights off certain…

Questions about COVID-19 vaccine boosters — like who is eligible and how to choose one — have dominated scientific discussions, news headlines, and dinner-table conversations recently, but the practice of…

The Centers for Disease Control and Prevention recently reported that overdose deaths exceeded 100,000 over a 12-month period for the first time in U.S. history. The grim milestone represents an…

For Simar Singh Bajaj ’24, the key to equity begins on the page. The history of science concentrator is still a few years from his planned career in medicine, but…

Compared with the Pfizer COVID-19 vaccine, the Moderna COVID-19 vaccine has a slightly lower risk of COVID-19 outcomes, including documented SARS-CoV-2 infection, symptomatic COVID-19, and COVID-19-related hospitalization, intensive care unit…